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Early diagnosis of contrast media-
induced nephropathy in intensive care 
 Matjaž Klemenc, Polona Likar
PP6-General Hospital of Nova Gorica  
Abstract — At the Research Department in hospital of Nova Gorica we are faced 
with new cathlab practice and problems connected with it. Together with other 
project partners we intend to investigate contrast media induced nephropathy 
by measuring the release of NGAL, which is considered to be a good biomarker 
for detecting reduced kidney function. Our first priority is extensive study of 
NGAL and develop special detecting lab-on-a chip that should be small and 
simple to use at every day hospital practice. Our second priority is to develop 
new and intensify pre-existing collaborations and exchange of knowledge 
between project partners.
Index Terms — Catlab practice, biomarker, Neutrophil gelatinease-associated 
lipocalin (NGAL)
————————————————————
1 GENERAL hOSPITAL OF NOVA GORICA
General Hospital of Nova Gorica is the youngest general hospital in Slovenia, from the health care program is the medium size Slovenian hospital, which is 
characterized by rapid growth and large dynamic processes. From an entrepreneurial 
point of view, the hospital is a large company and one of the largest companies in 
Primorska region.
The hospital was founded in 1956. At the beginning it was located in old adapted 
buildings and had four main departments: internal medicine, surgery, paediatrics 
and gynaecology. In the year of 1965 the state began to build new hospital which 
was finished in 1985. The new 536-bed hospital has a surgery, internal medicine, 
gynaecology, paediatrics, ophthalmology, ENT, orthopaedic departments. It has a 750 
employee, from which 82 specialists, 4 with PhD and 2 with BSc.
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2 RESEARCh DEPARTMENT
The research department in Hospital Nova Gorica is located at the unit of intensive care and cardiology. The rapid medical technology development requires constant 
education and follow new developments. At our research department doctors and 
researchers are working together to investigate appearing medical questions and 
seeking for new knowledge and better solutions. 
2.1 Research Areas 
The intensive care unit and cardiology were engaged in various research fields, such as (i) arterial hypertension, (ii) autonomic nervous system activity, (iii) baroreflex 
sensitivity, (iv) diastolic dysfunction of the left ventricle, (v) and vascular elasticity (vi). 
The ICU and cardiology department has already established a strong collaboration with 
University of Nova Gorica and Physiology and Pathology Department at University of 
Trieste through various studies exploring human nervous system [1-6]. We are also 
connected with researchers of Faculty of Computing and Informatics Institute (FRI) at 
University of Ljubljana .The result of this collaboration is special device and software 
for analysis of changes in velocity of blood in the arteries, which are now used in the 
study of elastic arteries in hypertensive patients [7-15]. Furthermore, The ICU and 
cardiology department has also established collaboration with Texas Heart Institute. 
As mentioned above, establishing collaborations with different institutions to reach 
constant flow of knowledge and technology transfer has always been our priority. We 
intend to continue with building a network of our collaborations through Trans2care 
project.
2.2 Activities in Trans2care project
Catheterization laboratory practice and contrast mediaLately medical contrast technology continues to evolve dramatically. As scanning 
technology advances so does the requirements for contrast media. At the hospitals 
we are faced with fast development of various types of contrast media with different 
enhancement effect and also wide range of side effects. The most common types of 
contrast medium for enhancing x-ray based imaging methods are iodine and barium. 
Various sorts of iodinated contrast media exist, with variations occurring between the 
osmolality, viscosity, absolute iodine content and concentration of iodine in different 
media [16]. However, recent surveys are shown that High Concentration Contrast 
Media (HCCM) allows a greater maximum enhancement in a shorter period of time 
using the same volume of contrast medium [16]. While modern contrast media are 
generally safe to use [17] medical conditions can be caused by the administration 
of various contrast media.  At the research department at Hospital of Nova Gorica 
we are focused on risk of contrast-medium induced nephropathy (CIN) in high risk 
patients, especially in patients with reduced kidney function. To diagnose the kidney 
failure the technology for diagnosis is required. For this reason we are interested in 
biomarkers for detecting early stages of CIN and supporting technology that should 
be small, simple, fast and with large data capacity.
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2.3 NGAL as biomarker
The recent studies show that Neutrophil gelatinase-associated lipocalin or NGAL (also known as lipocalin 2, oncogene protein24p33 or uterocalin) is appropriate 
biomarker for acute kidney injury [19]. This is small, robust protein that belongs 
to the lipocalin family of the proteins. It is expressed by neutrophils and various 
epithelia, including the renal proximal tubules. Because of its small molecular size 
and resistance to degardation it is readily excreted and detected in the urine. While 
the functions of NGAL are not fully understood, it appears to be upregulated in cells 
under stress. However, NGAL levels rise significantly in both urine and blood as a 
response to kidney injury what makes it a useful marker of such injury [18]. The NGAL 
is mostly quantified by researchbased ELISA assays, which are impractical in the 
clinical setting. The development of small lab-on-a chip for simple and quick clinical 
measurement of plasma and urine NGAL would make it easier. It would also enable 
clinical investigators to assess the potential of this molecule as a diagnostic marker 
or a marker for response to use of contrast media. 
3 hOSPITAL OF NOVA GORICA IN TRANS2CARE
Through Trans2care project we intend to study contrast induced release of NGAL. We will continue the collaboration with University of Nova Gorica to study the 
chemistry of NGAL and possibly develop specific lab-on-a-chip. We also see the 
possible connection with University in Trieste, where they can help us with specific 
studies of NGAL for instance reproducing in it vitro on endothelial cells, test NGAL 
on kidney cells (cytotoxicity assays). On the other hand we can offer other project 
partners data and knowledge of cardiovascular technology.
4 CONCLUSION
Through the initiated Trans2Care project we intend to contribute through the activities and studies aimed to a deeper understanding of NGAL function and 
developing detection technologies. That will help us at diagnostic of reduced kidney 
function and also at studies of contrast-media induced release of NGAL. On this way 
we can compare the safety of different types of contrast media. Our other goal is to 
connect with the research institutes, universities within the project partners to build 
the network of knowledge, innovation and technology transfer.
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